The value of magnetic resonance cholangiopancreatography for the exclusion of choledocholithiasis.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsHjartarson, Jón H
Björnsson, Einar S
MetadataShow full item record
CitationThe value of magnetic resonance cholangiopancreatography for the exclusion of choledocholithiasis. 2016, 51 (10):1249-56 Scand. J. Gastroenterol.
AbstractTo investigate the ability of Magnetic resonance cholangiopancreatography (MRCP) to exclude choledocholithiasis (CDL) in symptomatic patients.
Patients suspected of choledocholithiasis who underwent MRCP from 2008 through 2013 in a population based study at the National University Hospital of Iceland were retrospectively analysed, using ERCP and/or intraoperative cholangiography as a gold standard diagnosis for CDL.
Overall 920 patients [66% women, mean age 55 years (SD 21)] underwent MRCP. A total of 392 patients had a normal MRCP of which 71 underwent an ERCP investigation demonstrating a CBD stone in 29 patients. A normal MRCP was found to have a 93% negative predictive value (NPV) and 89% probability of having no CBD stone demonstrated as well as no readmission due to gallstone disease within six months following MRCP. During a 6-month follow-up period of the 321 patients who did not undergo an ERCP nine (2.8%) patients were readmitted with right upper quadrant pain and elevated liver tests which later normalised with no CBD stone being demonstrated, three (0.9%) patients were readmitted with presumed gallstone pancreatitis, two (0.6%) patients were readmitted with cholecystitis and two (0.6%) patients were lost to follow-up. Seven patients of those 321 underwent an intraoperative cholangiography (IOC) and all were negative for CBD stones. For the sub-group requiring ERCP following a normal MRCP the NPV was 63%.
Our results support the use of MRCP as a tool for exclusion of choledocholithiasis with the potential to reduce the amount of unnecessary ERCP procedures.
DescriptionTo access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked Files. This article is open access.
RightsArchived with thanks to Scandinavian journal of gastroenterology
- Selective use of magnetic resonance cholangiopancreatography in clinical practice may miss choledocholithiasis in gallstone pancreatitis.
- Authors: Srinivasa S, Sammour T, McEntee B, Davis N, Hill AG
- Issue date: 2010 Dec
- Diagnostic value of magnetic resonance cholangiopancreatography to detect bile duct stones in acute biliary pancreatitis.
- Authors: Lee SL, Kim HK, Choi HH, Jeon BS, Kim TH, Choi JM, Ku YM, Kim SW, Kim SS, Chae HS
- Issue date: 2018 Jan
- Utility of MRCP in clinical decision making of suspected choledocholithiasis: An institutional analysis and literature review.
- Authors: Badger WR, Borgert AJ, Kallies KJ, Kothari SN
- Issue date: 2017 Aug
- Role of magnetic resonance cholangiopancreatography for choledocholithiasis: analysis of patients with negative MRCP.
- Authors: Chang JH, Lee IS, Lim YS, Jung SH, Paik CN, Kim HK, Kim TH, Kim CW, Han SW, Choi MG, Jung IS
- Issue date: 2012 Feb
- Magnetic resonance cholangiopancreatography accurately predicts the presence or absence of choledocholithiasis.
- Authors: Hochwald SN, Dobryansky M BA, Rofsky NM, Naik KS, Shamamian P, Coppa G, Marcus SG
- Issue date: 1998 Nov-Dec